PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.81%
Revenue growth under 50% of 9698.HK's 19.09%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-11.22%
Negative gross profit growth while 9698.HK is at 15.05%. Joel Greenblatt would examine cost competitiveness or demand decline.
No Data
No Data available this quarter, please select a different quarter.
-126.45%
Negative operating income growth while 9698.HK is at 78.89%. Joel Greenblatt would press for urgent turnaround measures.
-6681.17%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-6600.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-6600.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
2.11%
Share reduction more than 1.5x 9698.HK's 12.26%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
2.11%
Diluted share reduction more than 1.5x 9698.HK's 12.26%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-100.00%
Dividend reduction while 9698.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
274.27%
OCF growth above 1.5x 9698.HK's 75.59%. David Dodd would confirm a clear edge in underlying cash generation.
269.63%
Positive FCF growth while 9698.HK is negative. John Neff would see a strong competitive edge in net cash generation.
133.95%
10Y revenue/share CAGR at 50-75% of 9698.HK's 255.47%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
-1.61%
Negative 5Y CAGR while 9698.HK stands at 255.47%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
13.41%
3Y revenue/share CAGR under 50% of 9698.HK's 255.47%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
3556.46%
10Y OCF/share CAGR above 1.5x 9698.HK's 37.06%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
338.17%
5Y OCF/share CAGR above 1.5x 9698.HK's 37.06%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
236.38%
3Y OCF/share CAGR above 1.5x 9698.HK's 37.06%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
-368.92%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-290.75%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-311.24%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
5.17%
Below 50% of 9698.HK's 220.27%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-4.71%
Negative 3Y equity/share growth while 9698.HK is at 220.27%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while 9698.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
-32.73%
Firm’s AR is declining while 9698.HK shows 19.05%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-11.06%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-17.72%
Negative asset growth while 9698.HK invests at 28.19%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-8.94%
We have a declining book value while 9698.HK shows 41.17%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-31.50%
We’re deleveraging while 9698.HK stands at 11.94%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
24.96%
SG&A growth well above 9698.HK's 4.68%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.